US Archives - Page 58 of 119 - European Medical Journal

Children Drive RSV Spread Within U.S. Households

Respiratory syncytial virus (RSV) transmission in U.S. households was examined in a new study that showed young children are the primary drivers of infection, spreading the virus to adults and other household members.

Hidden Cognitive Decline in MS: A New Concern

Cognitive decline in relapsing-remitting multiple sclerosis (RRMS) can progress independently of both relapses and MRI-detected disease activity, challenging traditional methods of monitoring MS progression, according to the results of a new study.

Deep Learning Enhances NSCLC Treatment Precision

A deep learning model offering a powerful tool for predicting how patients with advanced non-small cell lung cancer (NSCLC) will respond to immune checkpoint inhibitors (ICIs), potentially improving treatment personalization, has been newly developed.

Twice-Yearly Biologic Shows Long-Term Safety in Asthma

A 12-month interim analysis of the AGILE Phase III open-label extension study confirms that twice-yearly depemokimab, an ultra-long-acting anti-IL-5 biologic, maintains a favorable safety and efficacy profile in patients with type 2 asthma.

COVID-19 Booster Protection: How Long Does It Last?

Analysis of over 1.5 million U.S. adults in a new study has found that annual COVID-19 variant-targeted boosters provide meaningful protection against severe disease but lose effectiveness beyond 6 months.

Cancer Outcomes in Rheumatoid Arthritis: Increased Mortality Rates

A recent long-term population study from Western Australia has revealed critical insights into the relationship between rheumatoid arthritis (RA) and cancer outcomes.

Study Finds 99% of Psoriasis Diet Advice on Instagram Is Misinformation

Dietary recommendations for psoriasis on Instagram have been analyzed in a new study, which found that nearly all posts lack scientific credibility, with most advice coming from unqualified individuals.

Positive Survival Outcomes for Melanoma Brain Metastases in New Trial

A phase II trial evaluating the combination of pembrolizumab and bevacizumab in patients with untreated melanoma brain metastases (MBM) has demonstrated substantial clinical activity and promising survival outcomes.

Can AI Diagnose Unexplained Fainting?

A machine-learning classifier designed to assist healthcare professionals in accurately diagnosing the causes of transient loss of consciousness (TLOC) has been introduced in a new study.

Pediatric OSA: How Predictive is CPAP Pressure?

Continuous positive airway pressure (CPAP) therapy is a cornerstone in managing severe obstructive sleep apnea (OSA) in children.